存致癌风险!美食药局全球范围内召回常用降血压药物

2018-08-08 17:21

小弈编译

(本文为小弈自动翻译)

[(Title)] FDA issues worldwide recall of common blood pressure medication.


(FOX 46 WJZY) - A large medication recall has expanded again - now to a global scale.

大规模医疗召回活动再次扩大,如今已扩大到全球范围。

Valsartan, a prescription medication commonly used to treat blood pressure issues and heart failure, is now under a worldwide recall.

缬沙坦(Valsartan)是治疗血压问题和心力衰竭的常用处方药,目前正被全世界召回。

The U.S. Food and Drug Administration says the drug contains a cancer causing chemical called N-nitrosodimethylamine (NDMA). This chemical is toxic to the liver and other organs.

美国食品和药物管理局(FDA)说,该药含有一种致癌物质,称为N硝基苯丙胺(NDMA),这种化学物质对肝脏和其他器官具有毒性。

"The presence of NDMA was unexpected and is thought to be related to changes in the way the active substance was manufactured," the FDA said.

美国食品和药物管理局说:“NDMA的存在是出乎意料的,并且被认为与活性物质的生产方式的变化有关。”

When the initial recall was first announced a few weeks ago, it didn't include the United States and it just impacted the generic version.

当最初召回是在几个星期前首次宣布时,当时并不包括美国,而只是影响了通用版本。

"We have carefully assessed the valsartan-containing medications sold in the United States, and we've found that the valsartan sold by these specific companies does not meet our safety standards. This is why we've asked these companies to take immediate action to protect patients,"  said Janet Woodcock, M.D., director of the FDA's Center for Drug Evaluation and Research.

“我们仔细评估了在美国销售的含缬沙坦的药物,我们发现这些特定公司销售的缬沙坦不符合我们的安全标准。这就是为什么我们要求这些公司立即采取行动 保护患者,“FDA药物评估和研究中心主任医学博士Janet Woodcock说。

 

Now, the recall has gone global with the FDA adding new manufacturers to the list:

现在,随着美国食药局向该名单增添新的制造商,召回活动已变得全球性。


观后感

已有0人参与

0票 0票 0票 0票
棒呆 深奥 枯燥 什么
给小编个吻 和小编聊聊 按在地上揍 这也叫文章
棒呆 深奥 枯燥 什么
给小编个吻 和小编聊聊 按在地上揍 这也叫文章
反馈